A four-year study of more than 8,000 men between the ages of 50 to 75 who had an elevated risk for developing prostate cancer found that those who took the drug dutasteride (sold as Avodart) were less ...

European regulators are considering withdrawing market authorizations for certain hair loss and enlarged prostate treatments, including Organon’s (NYSE:OGN) Propecia, over concerns they can trigger ...

Please provide your email address to receive an email when new articles are posted on . Mesotherapy with dutasteride was effective and associated with no serious side effects in a cohort of patients ...

Sexual side effects from prescription medications often go undiscussed, yet they significantly impact men’s quality of life. While these medications play crucial roles in treating various health ...